GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (STU:NL0) » Definitions » Construction In Progress

GRAIL (STU:NL0) Construction In Progress : €0.0 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL Construction In Progress?

GRAIL's quarterly construction in progress increased from Sep. 2024 (€0.0 Mil) to Dec. 2024 (€1.2 Mil) but then declined from Dec. 2024 (€1.2 Mil) to Mar. 2025 (€0.0 Mil).

GRAIL's annual construction in progress declined from Dec. 2022 (€10.1 Mil) to Dec. 2023 (€7.3 Mil) and declined from Dec. 2023 (€7.3 Mil) to Dec. 2024 (€1.2 Mil).


GRAIL Construction In Progress Historical Data

The historical data trend for GRAIL's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Construction In Progress Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24
Construction In Progress
0.21 0.19 10.05 7.31 1.24

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.24 -

GRAIL Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


GRAIL Business Description

Traded in Other Exchanges
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

GRAIL Headlines

No Headlines